Search results
PROMOTED
How do worsening heart events dictate the long-term outcomes of patients with transthyretin amyloid cardiomyopathy (ATTR-CM) and can earlier intervention influence the disease trajectory in ATTR-CM? In this new sub-analysis from ATTRibute-CM, recorded onsite at ESC Heart Failure Congress (HFA) 2026, Prof Marianna Fontana (University College London, London, UK) sheds further light onto these…
View more
HFA 2026: Updates on ATTR-CM
Author(s):
Marianna Fontana
,
Added:
3 weeks ago
Video Series
Meta-analysis and Meta-regression Applicability
Author(s):
Alberto Cordero
,
Carlos G Santos-Gallego
,
Armando Oterino
,
et al
Added:
8 months ago
Review Article
Author(s):
Rajesh Kharbanda
Added:
1 year ago
EuroPCR 25 - A meta-analysis of the individual patient data from the PROTECTED TAVR and BHF PROTECT-TAVI studies show TAVI with cerebral embolic protection (CEP) may reduce the rate of disabling stroke compared to TAVI without CEP.We are joined by Prof Rajesh Kharbanda (Oxford Radcliffe Hospitals NHS Trust, Oxford, UK) to discuss outcomes from a meta-analysis investigating TAVI with or without…
View more
Same-day Discharge Following PCI: A Meta-analysis of RCTs
Author(s):
Ngoc Huy Nguyen
,
Thanh Ngoc Le
,
Hoai Thi Thu Nguyen
,
et al
Added:
11 months ago
Systematic Review
Author(s):
Ton Duy Mai
,
Tri Huynh Quang Ho
,
Sy Van Hoang
,
et al
Added:
1 year ago
Author(s):
Theodora Cristina Cruz de Assis
,
Henrique Pinheiro Rosa
,
Louise Buonalumi Tacito Yugar
,
et al
Added:
1 month ago
Renal Impact: Rivaroxaban Versus Vitamin K Antagonists in AF
Author(s):
Phong Phan Dinh
,
Tri Huynh Quang Ho
,
Hung Manh Pham
,
et al
Added:
1 year ago
Systematic Review
Author(s):
Gianluca Campo
Added:
1 year ago
ESC Congress 2024 — Complete revascularisation is safe, reduces ischemic events for up to 4 years, and does not affect long-term mortality.We are joined onsite by Dr Gianluca Campo (University of Ferrara, Ferrara, IT) to discuss the findings from EARTH-STEMI. Previous RCTs have supported the benefit of complete revascularisation in the overall population, however, this has not been confirmed in…
View more
Author(s):
Tian-le Li
,
Mao-long Fu
,
Li-hong Wang
,
et al
Added:
1 year ago
Author(s):
Andrew Wang
Added:
6 months ago
AHA Scientific Sessions 2025 – MAPLE-HCM responder analysis shows aficamten monotherapy led to greater treatment effect when compared to metoprolol monotherapy.Dr Andrew Wang (Duke University Medical Center, Durham, NC, US) presents a responder analysis from the MAPLE-HCM trial (NCT05767346), examining clinical responses to aficamten monotherapy versus metoprolol in patients with obstructive…
View more